Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **tooth mineral interface** describes the microscopic and nanoscopic boundary layers between tooth structures (such as enamel, dentin, and cementum) and the minerals composing them, primarily *hydroxyapatite* (Ca₁₀(PO₄)₆(OH)₂)[2][3][6]. This interface governs key properties including mechanical strength, resistance to fracture, and sensitivity to demineralization or therapeutic remineralization[2][3][4]. Unlike classical drug targets, it is a complex physical–biological–chemical landscape composed of mineral crystals, organic matrix proteins (such as collagen in dentin[3], or other matrix molecules[1]), and water. Agents including fluoride and calcium act at or near these interfaces to affect mineral integrity and remineralization, but the interface itself is not a protein, receptor, transporter, or enzyme[3][6]. Thus, "tooth mineral interface" is not recognized as a canonical molecular target in pharmacology or structural biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tooth mineral interface.